Marketing-authorisation holder · Ireland
Aspen Pharma Trading Limited
126 medicines in 5 countries, as authorisation holder and marketer.
Loading your page…
Marketing-authorisation holder · Ireland
126 medicines in 5 countries, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 126
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALKERANCompressa rivestita con film | Melphalan | Italy | Authorised | |
| ALKERAN 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA2 mg · Comprimido recubierto con película | Melphalan | Spain | Marketed | 2021 |
| Alkeran 2 mg, filmomhulde tablettenFilmomhulde tablet | Melphalan | Netherlands | Authorised | 1964 |
| Alkeran 50 mg Infuus, poeder en oplosmiddel voor oplossing voor infusiePoeder en oplosmiddel voor oplossing voor infusie | Melphalan | Netherlands | Authorised | 1973 |
| ALKERAN 50 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION50 mg · Polvo y disolvente para solución para perfusión | Melphalan | Spain | Authorised | 2021 |
| AZATIOPRINA ASPENCompressa rivestita con film | Azathioprine | Italy | Authorised | |
| BUSULFANO ASPEN 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA2 mg · Comprimido recubierto con película | Busulfan | Spain | Marketed | 1959 |
| Citanest 10 mg/ml, oplossing voor injectieOplossing voor injectie | Prilocaine | Netherlands | Authorised | 1984 |
| Citanest 20 mg/ml, oplossing voor injectieOplossing voor injectie | Prilocaine | Netherlands | Authorised | 1984 |
| CLORAMBUCILO ASPEN 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA2 mg · Comprimido recubierto con película | Chlorambucil | Spain | Marketed | 2020 |
| Deca-Durabolin 50 mg/ml, oplossing voor injectieOplossing voor injectie | Nandrolone | Netherlands | Authorised | 1990 |
| DIPRIVANEmulsione per infusione endovenosa | Propofol | Italy | Authorised | |
| Diprivan-10 emulsie voor injectie of infusie, 10 mg/mlEmulsie voor infusie, Emulsie voor injectie | Propofol | Netherlands | Authorised | 1987 |
| Diprivan-20 emulsie voor injectie of infusie, 20 mg/mlEmulsie voor injectie, Emulsie voor infusie | Propofol | Netherlands | Authorised | 1996 |
| DIPRIVAN 20 mg/ml EMULSION PARA PERFUSION20 mg · Emulsión inyectable y para perfusión | Propofol | Spain | Marketed | 1996 |
| Eltroxin 100 microgram, tablettenTablet | Levothyroxine | Netherlands | Authorised | 1981 |
| Eltroxin 50 microgram, tablettenTablet | Levothyroxine | Netherlands | Authorised | 1981 |
| EMLACrema | Lidocaine, Prilocaine | Italy | Authorised | |
| EMLA 25 mg/g + 25 mg/g CREMA25 mg + 25 mg · Crema | Lidocaine, Prilocaine | Spain | Marketed | 1997 |
| emla, hydrofiele creme 5%Crème | Lidocaine, Prilocaine | Netherlands | Authorised | 1987 |
| Emla, pleisterPleister voor transdermaal gebruik | Lidocaine, Prilocaine | Netherlands | Authorised | 1993 |
| GRACIALCompressa | Desogestrel, Ethinyl estradiol | Italy | Authorised | |
| GRACIAL COMPRIMIDOS0,025 mg + 0,04 mg + 0,125 mg + 0,03 mg · Comprimido | Desogestrel, Ethinyl estradiol | Spain | Marketed | 2000 |
| Imuran 50 mg filmom obložene tabletefilmom obložena tableta | Azathioprine | Croatia | Marketed | 2017 |
| KEMADREN 5 mg COMPRIMIDOS5 mg · Comprimido | Procyclidine | Spain | Marketed | 1962 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 54 | 54 | 0 | CompaniesAll medicines |
| Spain | 35 | 17 | 18 | CompaniesAll medicines |
| Italy | 18 | 18 | 0 | CompaniesAll medicines |
| Romania | 18 | 0 | 18 | CompaniesAll medicines |
| Croatia | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of France, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Other companies in the same group.
Ranked by their number of medicines.